Common use of Confidentiality & Public Notices Clause in Contracts

Confidentiality & Public Notices. Except where compliance with this Section 10.1 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedica, who when required, shall use its best efforts to provide such authorization and approval to WOW in a timely manner as shall permit compliance by WOW with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW and ZoMedica shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW or WOW's Business discovered or acquired by it, its representatives or accountants as a result of WOW making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW or WOW's Business and ZoMedica agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica discovered or acquired by it, its representatives or accountants as a result of ZoMedica making available to it any information, books, accounts, records or other data and information relating to ZoMedica and WOW agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.3 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaRevive, who when required, shall use its best efforts to provide such authorization and approval to WOW Mercury in a timely manner as shall permit compliance by WOW Mercury with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Mercury and ZoMedica Revive shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Revive agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Mercury or WOW's Mercury’s Business discovered or acquired by it, its representatives or accountants as a result of WOW Mercury making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Mercury or WOW's Mercury’s Business and ZoMedica Revive agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Mercury agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Revive discovered or acquired by it, its representatives or accountants as a result of ZoMedica Revive making available to it any information, books, accounts, records or other data and information relating to ZoMedica Revive and WOW Mercury agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.3 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaTantalex, who when required, shall use its best efforts to provide such authorization and approval to WOW Lynnwood in a timely manner as shall permit compliance by WOW Lynnwood with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Xxxxxxxx and ZoMedica Tantalex shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Tantalex agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Lynnwood or WOWLynnwood's Business discovered or acquired by it, its representatives or accountants as a result of WOW Lynnwood making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Lynnwood or WOWLynnwood's Business and ZoMedica Tantalex agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Xxxxxxxx agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Tantalex discovered or acquired by it, its representatives or accountants as a result of ZoMedica Tantalex making available to it any information, books, accounts, records or other data and information relating to ZoMedica Tantalex and WOW Lynnwood agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 would result in a breach of applicable lawas may be required by law or the CSE, notices, releases, statements and communications to Third Parties, including employees no public disclosure of the parties transactions contemplated hereby will be made by CanaFarma or any of its authorized representatives without consent and approval of the Company or by the Company without the consent and approval of CanaFarma. CanaFarma and the press, Company agree to cooperate in connection with all publicity and press releases relating to the transactions contemplated by this Agreement will be made only in such manner as shall be Agreement. The Company, CanaFarma and its authorized and approved by ZoMedica, who when required, shall use its best efforts to provide such authorization and approval to WOW in a timely manner as shall permit compliance by WOW with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW and ZoMedica representatives shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement that is not otherwise generally available to the public ("Confidential Information") for a period of one year following the termination of this Agreement. In the event that the issuance of the Resulting Issuer Shares provided for Transaction as contemplated in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica agrees CanaFarma agree that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW the Company or WOWthe Company's Business discovered or acquired by itthem, its their representatives or accountants as a result of WOW the Company making available to itthem, its their representatives and accountants, any information, books, accounts, records or other data and information relating to WOW the Company or WOWthe Company's Business and ZoMedica agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica discovered or acquired by it, its representatives or accountants as a result of ZoMedica making available to it any information, books, accounts, records or other data and information relating to ZoMedica and WOW CanaFarma agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person. The Company agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to CanaFarma or the CanaFarma Shareholders discovered or acquired by it, its representatives or accountants as a result of CanaFarma or the CanaFarma Shareholders making available to it, any information, books, accounts, records or other data and information relating to CanaFarma and the Company agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person. Notwithstanding the foregoing, it is hereby acknowledged and agreed to by CanaFarma that: (i) the Company or its representatives shall be at liberty to disclose any Confidential Information in the course of complying with applicable laws, regulations or the requirements of any lawful authority; and (ii) nothing in this Section 8.1 shall prevent the Company from entering into a business of a similar nature to the business presently or hereafter conducted by CanaFarma.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.3 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaAuxico, who when required, shall use its best efforts to provide such authorization and approval to WOW Telferscot in a timely manner as shall permit compliance by WOW Telferscot with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Telferscot and ZoMedica Auxico shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Auxico agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Telferscot or WOWTelferscot's Business discovered or acquired by it, its representatives or accountants as a result of WOW Telferscot making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Telferscot or WOWTelferscot's Business and ZoMedica Auxico agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Telferscot agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Auxico discovered or acquired by it, its representatives or accountants as a result of ZoMedica Auxico making available to it any information, books, accounts, records or other data and information relating to ZoMedica Auxico and WOW Telferscot agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 would result in a breach of applicable lawas may be required by law or the CSE, notices, releases, statements and communications to Third Parties, including employees no public disclosure of the parties transactions contemplated hereby will be made by the Company or any of the Dropleaf Securityholders without consent and approval of the Purchaser or by the Purchaser without the consent and approval of the Company. The Company and the press, Purchaser agree to cooperate in connection with all publicity and press releases relating to the transactions contemplated by this Agreement will be made only in such manner as shall be authorized Agreement. The Purchaser, the Company and approved by ZoMedica, who when required, shall use its best efforts to provide such authorization and approval to WOW in a timely manner as shall permit compliance by WOW with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW and ZoMedica the Dropleaf Securityholders shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement that is not otherwise generally available to the public ("Confidential Information") for a period of one year following the termination of this Agreement. In the event that the issuance of the Resulting Issuer Shares provided for Transaction as contemplated in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica The Company and the Dropleaf Securityholders agree that they will not, directly or indirectly, make reciprocal use for their own purposes of any information or confidential data relating to the Purchaser or the Purchaser's Business discovered or acquired by them, their representatives or accountants as a result of the Purchaser making available to them, their representatives and accountants, any information, books, accounts, records or other data and information relating to the Purchaser or the Purchaser's Business and the Company and the Dropleaf Securityholders agree that they will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person. The Purchaser agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW the Company or WOW's Business the Dropleaf Securityholders discovered or acquired by it, its representatives or accountants as a result of WOW the Company or the Dropleaf Securityholders making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW or WOW's Business the Company and ZoMedica agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica discovered or acquired by it, its representatives or accountants as a result of ZoMedica making available to it any information, books, accounts, records or other data and information relating to ZoMedica and WOW the Purchaser agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.. Notwithstanding the foregoing, it is hereby acknowledged and agreed to by the Company and the Dropleaf Securityholders that:

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.3 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaDiitalk, who when required, shall use its best efforts to provide such authorization and approval to WOW PPK in a timely manner as shall permit compliance by WOW PPK with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW PPK and ZoMedica Diitalk shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Diitalk agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW PPK or WOW's PPK’s Business discovered or acquired by it, its representatives or accountants as a result of WOW PPK making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW PPK or WOW's PPK’s Business and ZoMedica Diitalk agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW PPK agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Diitalk discovered or acquired by it, its representatives or accountants as a result of ZoMedica Diitalk making available to it any information, books, accounts, records or other data and information relating to ZoMedica Diitalk and WOW PPK agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.3 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaTantalex, who when required, shall use its best efforts to provide such authorization and approval to WOW Lynnwood in a timely manner as shall permit compliance by WOW Lynnwood with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Lynnwood and ZoMedica Tantalex shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Tantalex agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Lynnwood or WOWLynnwood's Business discovered or acquired by it, its representatives or accountants as a result of WOW Lynnwood making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Lynnwood or WOWLynnwood's Business and ZoMedica Tantalex agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Lynnwood agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Tantalex discovered or acquired by it, its representatives or accountants as a result of ZoMedica Tantalex making available to it any information, books, accounts, records or other data and information relating to ZoMedica Tantalex and WOW Lynnwood agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.1 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaSeller, who when required, required shall use its best efforts to provide such authorization and approval to WOW Purchaser in a timely manner as shall permit compliance by WOW Purchaser with all continuous disclosure to any regulatory authority Regulatory Body or obligations under any applicable securities regulations. WOW Purchaser, Seller and ZoMedica Seller's Shareholders shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares or Exchange Options provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Seller and Seller's Shareholders agree that they will not, directly or indirectly, make reciprocal use for their own purposes of any information or confidential data relating to Purchaser or Purchaser's Business discovered or acquired by them, their representatives or accountants as a result of Purchaser making available to them, their representatives and accountants, any information, books, accounts, records or other data and information relating to Purchaser or Purchaser's Business and Seller and Seller's Shareholders agree that they will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person. Purchaser agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Seller or WOWSeller's Business Shareholders discovered or acquired by it, its representatives or accountants as a result of WOW Seller or Seller's Shareholders making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW or WOW's Business Seller; and ZoMedica agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica discovered or acquired by it, its representatives or accountants as a result of ZoMedica making available to it any information, books, accounts, records or other data and information relating to ZoMedica and WOW Purchaser agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 8.1 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaForrester, who when required, shall use its best efforts to provide such authorization and approval to WOW Acme in a timely manner as shall permit compliance by WOW Acme with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Acme and ZoMedica Forrester shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica Forrester agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Acme or WOWAcme's Business discovered or acquired by it, its representatives or accountants as a result of WOW Acme making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Acme or WOWAcme's Business and ZoMedica Forrester agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Acme agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica Forrester discovered or acquired by it, its representatives or accountants as a result of ZoMedica Forrester making available to it any information, books, accounts, records or other data and information relating to ZoMedica Forrester and WOW Acme agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 7.1 would result in a breach of applicable law, notices, releases, statements and communications to Third Parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicathe Corporation, who when required, shall use its best efforts to provide such authorization and approval to WOW the Purchaser in a timely manner as shall permit compliance by WOW the Purchaser with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW The Purchaser, the Corporation and ZoMedica the NP Vendors shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Exchange Shares provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica The Corporation and the NP Vendors agree that they will not, directly or indirectly, make reciprocal use for their own purposes of any information or confidential data relating to the Purchaser or the Purchaser’s Business discovered or acquired by them, their representatives or accountants as a result of the Purchaser making available to them, their representatives and accountants, any information, books, accounts, records or other data and information relating to the Purchaser or the Purchaser’s Business and the Corporation and the NP Vendors agree that they will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired by any other Person. The Purchaser agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW the Corporation or WOW's Business the NP Vendors discovered or acquired by it, its representatives or accountants as a result of WOW making available to it, its representatives and accountants, any information, books, accounts, records the Corporation or other data and information relating to WOW or WOW's Business and ZoMedica agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica discovered or acquired by it, its representatives or accountants as a result of ZoMedica the NP Vendors making available to it any information, books, accounts, records or other data and information relating to ZoMedica the Corporation and WOW the Purchaser agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.

Confidentiality & Public Notices. Except where compliance with this Section 10.1 12.16 would result in a breach of applicable law, notices, releases, statements and communications to Third Partiesthird parties, including employees of the parties and the press, relating to transactions contemplated by this Agreement will be made only in such manner as shall be authorized and approved by ZoMedicaFLRish, who when required, shall use its best efforts to provide such authorization and approval to WOW Lineage in a timely manner as shall permit compliance by WOW Lineage with all continuous disclosure to any regulatory authority or obligations under any applicable securities regulations. WOW Lineage and ZoMedica FLRish shall maintain the confidentiality of any information received from each other in connection with the transactions contemplated by this Agreement. In the event that the issuance of the Resulting Issuer Shares Merger Consideration provided for in this Agreement is not consummated, each party shall return any confidential schedules, documents or other written information to the party who provided same in connection with this Agreement. ZoMedica FLRish agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to WOW Lineage or WOW's Lineage Business discovered or acquired by it, its representatives or accountants as a result of WOW Lineage making available to it, its representatives and accountants, any information, books, accounts, records or other data and information relating to WOW Lineage or WOW's Lineage’s Business and ZoMedica FLRish agrees that it will not disclose, divulge or communicate orally, in writing or otherwise (directly or indirectly), any such information or confidential data so discovered or acquired by any other Person. WOW Lineage agrees that it will not, directly or indirectly, make reciprocal use for its own purposes of any information or confidential data relating to ZoMedica FLRish or FLRish Business discovered or acquired by it, its representatives or accountants as a result of ZoMedica FLRish making available to it any information, books, accounts, records or other data and information relating to ZoMedica FLRish or FLRish Business and WOW Lineage agrees that it will not disclose, divulge or communicate orally, in writing or otherwise, any such information or confidential data so discovered or acquired to any other Person.